Protac compounds targeting c-kit or pdgfrα, compositions and uses thereof
TW202629167APending Publication Date: 2026-07-16SHENZHEN TARGETRX INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114137619
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-09-23
- Filing Date
- 2025-09-30
- Publication Date
- 2026-07-16
Abstract
This invention relates to compounds of formula (I), or tautomers, stereoisomers, prodrugs, crystal forms, pharmaceutically acceptable salts, hydrates or solvates thereof, pharmaceutical compositions thereof, and their use in the treatment of c-Kit or PDGFRα-related diseases. (No further information provided.)
Need to check novelty before this filing date? Find Prior Art